| Bioactivity | SMCY peptide inhibits the binding of iodinated standard peptide to HLA-B7 with an IC50 of 34 nM. As an epitope of the H-Y antigen, SMCY peptide can be presented by the HLA-B7 molecule and recognized by specific T cells, leading to transplant rejection[1]. |
| CAS | 169312-12-3 |
| Sequence | Ser-Pro-Ser-Val-Asp-Lys-Ala-Arg-Ala-Glu-Leu |
| Shortening | SPSVDKARAEL |
| Formula | C49H85N15O18 |
| Molar Mass | 1172.29 |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
| Reference | [1]. Wang W, et al. Human H-Y: a male-specific histocompatibility antigen derived from the SMCY protein. Science. 1995 Sep 15;269(5230):1588-90. |
SMCY peptide
CAS: 169312-12-3 F: C49H85N15O18 W: 1172.29
SMCY peptide inhibits the binding of iodinated standard peptide to HLA-B7 with an IC50 of 34 nM. As an epitope of the H-
Sales Email：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.